Telo

Mission BioCapital Announces $275 Million Fund V

Retrieved on: 
Thursday, November 4, 2021

Mission BioCapital V LP is more than double the size of the firms prior fund.

Key Points: 
  • Mission BioCapital V LP is more than double the size of the firms prior fund.
  • Our team empowers exceptional biotech entrepreneurs from all walks of life, said Peter D. Parker, co-founder and managing general partner of Mission BioCapital.
  • Mission BioCapital has already funded seven companies from the new fund, including four where it has played a co-founder role ARase Therapeutics, Arclight Therapeutics LLC, Jupiter Bioventures, and Telo Therapeutics.
  • Prior to joining Mission BioCapital, Dr. Tregay served as founder, president and chief executive officer of FORMA Therapeutics (NASDAQ: FMTX), raising $875 million in non-dilutive funding alongside venture investments of $44 million and advancing seven clinical drug candidates.

Telo Genomics Completes First Tranche of Oversubscribed Private Placement

Retrieved on: 
Friday, July 2, 2021

Toronto, Ontario--(Newsfile Corp. - July 2, 2021) - Telo Genomics Corp. (TSXV: TELO) (the "Company" or "TELO") announces that it has closed the first tranche of its previously announced non-brokered private placement ("Offering") of units (the "Units").

Key Points: 
  • Toronto, Ontario--(Newsfile Corp. - July 2, 2021) - Telo Genomics Corp. (TSXV: TELO) (the "Company" or "TELO") announces that it has closed the first tranche of its previously announced non-brokered private placement ("Offering") of units (the "Units").
  • The Company issued a total of 4,185,500 Units at a price of $0.50 per Unit for gross proceeds of $2,092,750 under the first tranche of the Offering.
  • Each Warrant will entitle the holder to acquire one additional Common Share at a price of $0.75 per Common Share until December 30, 2022.
  • Telo Genomics is a biotech company pioneering the most comprehensive telomere platform in the industry with powerful applications and prognostic solutions.

Telo Genomics Announces AGM Voting Results and Provides Corporate Update

Retrieved on: 
Wednesday, March 24, 2021

The samples received passed the Company's accession quality control and TELO's technical team has already started to process the received samples.

Key Points: 
  • The samples received passed the Company's accession quality control and TELO's technical team has already started to process the received samples.
  • TELO has advanced discussions with its Clinical Advisory Board and strategic consultant, BioCore Strategies, LLC, for the purpose of expanding the commercial applications of its proprietary diagnostic/prognostic technology platform TeloView.
  • TELO also announces the appointment of Mr. Christopher Ross as the Company's CFO effective April 01, 2021.
  • Telo Genomics is a biotech company pioneering the most comprehensive telomere platform in the industry with powerful applications and prognostic solutions.

Telo Unveils Proprietary Multi-Signal Nuisance Call Detection Feature for Telephone Carriers

Retrieved on: 
Tuesday, May 5, 2020

"Nuisance call detection helps restore subscribers' trust in phone calls and fulfills Telo's vision of delivering trusted communications solutions to all our customers," said Chris Brunner, CEO, Telo.

Key Points: 
  • "Nuisance call detection helps restore subscribers' trust in phone calls and fulfills Telo's vision of delivering trusted communications solutions to all our customers," said Chris Brunner, CEO, Telo.
  • Now, with Nuisance Call Detection, the default CNAM value for these problematic calls can be replaced with a "NUISANCE LIKELY" or similar response.
  • "We have worked for years, continuously improving our algorithm to ensure that telephone carriers receive the most accurate results," said Jason Rudder, CTO,Telo, describing Nuisance Call Detection.
  • Telo is a leader in making trusted communications simple by providing advanced caller identification, nuisance detection, and CID verification services through OpenCNAM.

Telo and Partners Team Up to Bring Subscribers Caller ID for Official COVID-19 Toll-Free Numbers

Retrieved on: 
Monday, March 30, 2020

The CNAM for all Toll-Free numbers utilized by HHS, and other government organizations assisting the general public with pandemic related issues, will be displayed to subscribers across hundreds of telephone carriers.

Key Points: 
  • The CNAM for all Toll-Free numbers utilized by HHS, and other government organizations assisting the general public with pandemic related issues, will be displayed to subscribers across hundreds of telephone carriers.
  • Telo , Somos , and First Orion each have a critical role in providing this service to the public.
  • Within minutes the information for pandemic-related lines was being displayed to the millions of subscribers served by their carrier customers."
  • We've been working collaboratively to put the necessary data safely and securely in TFN Identity, the trusted, centralized registry for Toll-Free Number Caller IDinformation."

Kimberly DellaTorre Named Vice President of Customer Success at Telo

Retrieved on: 
Tuesday, March 17, 2020

SAN JUAN, Puerto Rico, March 17, 2020 /PRNewswire/ --Telo has named Kimberly DellaTorre as Vice President of Customer Success, adding another key member to the executive sales team.

Key Points: 
  • SAN JUAN, Puerto Rico, March 17, 2020 /PRNewswire/ --Telo has named Kimberly DellaTorre as Vice President of Customer Success, adding another key member to the executive sales team.
  • "As Telo continues its aggressive growth, Kimberly stood out to us as a natural fit to ensure our continued success," said Brent James, COO, Telo.
  • "I am thrilled to be named the VP of Customer Success and I appreciate the confidence that the Telo team has placed in me," said DellaTorre regarding her appointment.
  • "Telo has an amazing team of talented people providing advanced technologies that bring trusted communications to our customers and ultimately the end subscriber.

John Skousen Named Vice President of Carrier Sales at Telo

Retrieved on: 
Tuesday, March 3, 2020

SAN JUAN, Puerto Rico, March 3, 2020 /PRNewswire/ --Telo, a leader in making trusted communications simple for the global communications industry, announced today that John Skousen has been named Vice President of Carrier Sales.

Key Points: 
  • SAN JUAN, Puerto Rico, March 3, 2020 /PRNewswire/ --Telo, a leader in making trusted communications simple for the global communications industry, announced today that John Skousen has been named Vice President of Carrier Sales.
  • In this role, Skousen will assume responsibility for all telecommunication carrier sales as Telo builds on its market and product momentum.
  • Mr. Skousen brings over 20 years of sales leadership to his new role.Before joining Telo, John held similar positions at companies such as 10X People and Neustar, building partnerships with a diverse set of major telecommunications companies.
  • "The timing could not have been better for John to step into this role at Telo.

Telo Appoints Veteran Industry Executive Joe McNulty Chief Revenue Officer to Head Up Sales and Growth for the Company.

Retrieved on: 
Tuesday, July 3, 2018

ATLANTA, July 3, 2018 /PRNewswire/ -- Telo has hired industry veteran Joe McNulty as Chief Revenue Officer.

Key Points: 
  • ATLANTA, July 3, 2018 /PRNewswire/ -- Telo has hired industry veteran Joe McNulty as Chief Revenue Officer.
  • Chris Brunner, Chief Executive Officer at Telo, said, "We are delighted to be welcoming Joe to Telo.
  • His deep product, sales, and customer experience in, telecom, financial, ad tech, retail will help us spread our value-proposition more effectively."
  • Brent James, Chief Operating Officer at Telo, added, "Joe has demonstrated that his vision for the evolution of caller identification services aligns with that of ours here at Telo.